Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Ming Hsu

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 25, 2009
Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancerChia-Chi Lin, Chih-Hung Hsu, Jason C Cheng, et al.
Plos One|January 1, 2016
The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic DiseasesYun Chiang, James Chih-Hsin Yang, Feng-Ming Hsu, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 9, 2017
Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patientsYu-Sen Huang, Jenny Ling-Yu Chen, Feng-Ming Hsu, et al.
Chronobiology International|January 29, 2016
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinomaFeng-Ming Hsu, Wei-Hsien Hou, Chao-Yuan Huang, et al.
Hepatology (Baltimore, Md.)|June 25, 2017
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in miceChiao-Ling Tsai, Wei-Lin Liu, Feng-Ming Hsu, et al.
Biomedicines|March 28, 2025
Clinical Outcome of Conversion Surgery for Stage IV Esophageal Cancer Following ChemoradiationHu-Lin Christina Wang, Ke-Cheng Chen, Pei-Ming Huang, et al.
Journal of Neuro-Oncology|June 8, 2021
Peri-radiosurgical administration of bevacizumab improves radiographic response to single and fractionated stereotactic radiosurgery for large brain metastasisYi-Lun Chen, Abel Po-Hao Huang, Chia-Chun Wang, et al.
Cancer Medicine|March 29, 2022
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimensWei-Li Ma, Chia-Chi Lin, Feng-Ming Hsu, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 3, 2021
Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancerJenny Ling-Yu Chen, Chun-Kai Pan, Yu-Li Lin, et al.
European Journal of Radiology|September 28, 2025
Multimodal radiomic analysis to determine high-Consistency prognostic phenotypes associated with epidermal growth factor receptor mutations in non-small cell lung cancer brain metastasesChe-Yu Hsu, Hsin-Han Tsai, Ting-Li Chen, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|March 25, 2009
Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancerChia-Chi Lin, Chih-Hung Hsu, Jason C Cheng, et al.
Plos One|January 1, 2016
The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic DiseasesYun Chiang, James Chih-Hsin Yang, Feng-Ming Hsu, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 9, 2017
Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patientsYu-Sen Huang, Jenny Ling-Yu Chen, Feng-Ming Hsu, et al.
Chronobiology International|January 29, 2016
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinomaFeng-Ming Hsu, Wei-Hsien Hou, Chao-Yuan Huang, et al.
Hepatology (Baltimore, Md.)|June 25, 2017
Targeting histone deacetylase 4/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in miceChiao-Ling Tsai, Wei-Lin Liu, Feng-Ming Hsu, et al.
Biomedicines|March 28, 2025
Clinical Outcome of Conversion Surgery for Stage IV Esophageal Cancer Following ChemoradiationHu-Lin Christina Wang, Ke-Cheng Chen, Pei-Ming Huang, et al.
Journal of Neuro-Oncology|June 8, 2021
Peri-radiosurgical administration of bevacizumab improves radiographic response to single and fractionated stereotactic radiosurgery for large brain metastasisYi-Lun Chen, Abel Po-Hao Huang, Chia-Chun Wang, et al.
Cancer Medicine|March 29, 2022
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimensWei-Li Ma, Chia-Chi Lin, Feng-Ming Hsu, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 3, 2021
Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancerJenny Ling-Yu Chen, Chun-Kai Pan, Yu-Li Lin, et al.
European Journal of Radiology|September 28, 2025
Multimodal radiomic analysis to determine high-Consistency prognostic phenotypes associated with epidermal growth factor receptor mutations in non-small cell lung cancer brain metastasesChe-Yu Hsu, Hsin-Han Tsai, Ting-Li Chen, et al.
Pageof 8